2007-08-21 11:30:01 CEST

2007-08-21 11:30:01 CEST


REGULATED INFORMATION

English Finnish
Cencorp - Quarterly report

Cencorp Corporation Interim Report for 1 January - 30 June 2007


April-June 2007                                                                 

Net sales amounted to EUR 4.1 (6.8) million                                     
Operating profit (EBIT) totalled EUR -0.6 (0.1) million                         
Profit before taxes was EUR -1.0 (-0.2) million                                 
Equity ratio stood at 1.9% (20.7%).                                             

The figures given for comparison are those for the corresponding period in the  
previous year unless otherwise stated.                                          

The Interim Report has been prepared in accordance with IAS 34 Interim Financial
Reporting.                                                                      


Group's key figures                                                             

--------------------------------------------------------------------------------
| (unaudited)           |          |          |          |          |          |
--------------------------------------------------------------------------------
| EUR 1,000             | 4-6/2007 | 4-6/2006 | 1-6/2007 | 1-6/2006 | 1-12/200 |
|                       |          |          |          |          | 6        |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Net sales             | 4 077    | 6 817    | 7 897    | 12 760   | 19 974   |
--------------------------------------------------------------------------------
| Operating profit/loss | -636     | 141      | -1 654   | -1 101   | -3 348   |
| (EBIT)                |          |          |          |          |          |
--------------------------------------------------------------------------------
| % of net sales        | -16 %    | 2 %      | -21 %    | -9 %     | -17 %    |
--------------------------------------------------------------------------------
| Profit/loss before    | -970     | -191     | -2 305   | -1 630   | -4 874   |
| taxes (EBT)           |          |          |          |          |          |
--------------------------------------------------------------------------------
| % of net sales        | -24 %    | -3 %     | -29 %    | -13 %    | -24 %    |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Research and          | 263      | 67       | 466      | 254      | 512      |
| development costs     |          |          |          |          |          |
--------------------------------------------------------------------------------
| % of net sales        | 7 %      | 1 %      | 6 %      | 2 %      | 2 %      |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Equity ratio, %       | 2 %      | 21 %     | 2 %      | 21 %     | 13 %     |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Personnel on average  | 129      | 192      | 135      | 199      | 185      |
--------------------------------------------------------------------------------
| Personnel at the end  | 132      | 187      | 132      | 187      | 156      |
| of period             |          |          |          |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Profit/share          | -0.04    | -0.01    | -0.09    | -0.05    | -0.14    |
| (diluted), EUR        |          |          |          |          |          |
--------------------------------------------------------------------------------


Net sales and earnings performance                                              

April-June 2007                                                                 

Net sales in April-June 2007 totalled EUR 4.1 million (EUR 6.8 million) while   
operating profit (EBIT) amounted to EUR -0.6 million (EUR 0.1 million). The     
Group's net financial items were EUR -0.3 (-0.3) million. Profit before taxes   
totalled EUR -1.0 (-0.2) million. Earnings per share were EUR -0.04 (-0.01).    

                                                                                

January-June 2007                                                               

Cencorp's net sales amounted to EUR 7.9 (12.8) million. Operating profit was EUR
-1.7 (-1.1) million. The Group's net financial items for the review period were 
EUR                                                                             
-0.6 (-0.5) million. Profit before taxes totalled EUR -2.3 (-1.6) million. The  
net profit for the period was EUR -2.3 (-1.6) million. Diluted earnings per     
share were EUR                                                                  
-0.09 (-0.05). Measures launched in the previous financial year to improve      
business efficiency affect as planned and the group's fixed costs were EUR 1.8  
million less than in the previous year.                                         

Cencorp Corporation's net sales came from one business segment: the automation  
and testing business. The laser business, which has been moved to Cencorp       
Corporation's subsidiary Singulase Corporation, did not generate any revenue in 
the review period, as the company still concentrated on product development.    
Product development has been delayed by more than one year due to factors       
outside the Group's control. The operating loss of the automation and testing   
business amounted to EUR -1.5 (-1.0) million, while earnings before taxes stood 
at EUR -2.2 (-1.5) million and the net loss for the period at EUR -2.2 (-1.5)   
million. Singulase Corporation recorded an operating profit, profit before taxes
and net loss for the period of EUR -0.1 (-0.1) million.                         


Balance sheet and financing                                                     

The balance sheet figures at 30 June 2007 are compared to those at 31 December  
2006.                                                                           

At the end of the review period, the balance sheet total was EUR 18.3 (21.1)    
million. The company's cash flow after investments was EUR 0.6 (-2.6)   million,
while interest-bearing net debts at the end of the review period amounted to EUR
13.2 (13.7) million. Accounts receivables decreased to EUR 3.8 (5.6) million,   
and inventories decreased to EUR 4.8 (5.2) million.                             

Non-interest-bearing liabilities amounted to EUR 4.4 (4.8) million and interest 
bearing liabilities to EUR 14.2 (14.6) million. The equity ratio was 1.9%       
(12.7%). Gross investments in January-June totalled EUR 0.04 (0.4) million, or  
1.0% (2.2%) of the period's net sales, and mainly came from product development.



Events in the review period                                                     


Details about events in the review period are available in Cencorp              
Corporation's stock exchange releases on Cencorp's website at www.cencorp.com.  

New Vice President, Sales and Marketing                                         

M.Sc. Mr. Kimmo Akiander (B. 1969) has been nominated as Vice President, Sales  
and Marketing of Cencorp Corporation starting on April 10, 2007. Mr. Akiander   
reports to CEO Jouni Suutarinen.                                                

Mr. Kimmo Akiander has previously worked as Sales and Marketing Director in     
Business Unit Systems of Efore Oyj. Before Efore Oyj he worked as a Key account 
manager for Motorola in Ascom Energy Systems GmbH.                              

Decisions of The Annual General Meeting of Cencorp Corporation held on April 17,
2007                                                                            

The financial statements for the fiscal year 2006 were approved. In accordance  
with the Board's proposal, it was resolved that no dividend shall be paid for   
the fiscal year January 1 - December 31, 2006. Likewise, it was resolved that   
the net loss of the fiscal year 2006 will be entered in the retained earnings   
account. Release from liability for the fiscal year January 1 -  December 31,   
2006 was granted to the members of the parent company's Board and the CEOs      
employed by the company during the fiscal year.                                 

The Annual General Meeting passed a resolution to elect three members to the    
Board. The previous members elected to the Board were Mr. Jorma Kielenniva, Mr. 
Markku Jokela and Mr. Sauli Kiuru.                                              

At the Board's organization meeting that was held after the Annual General      
Meeting, Jorma Kielenniva was elected Chairman of the Board and Markku Jokela   
Vice Chairman of the Board. Cencorp´s Vice President, Legal Affairs Mr. Ville   
Parpola continues as the secretary of the board. Jorma Kielenniva and Markku    
Jokela were elected as members of the Nomination and Compensation Committee. Mr 
Jorma Kielenniva was elected as the Chairman of the Nomination and Compensation 
Committee.                                                                      

Tilintarkastus Tuokko Oy was elected as the Company's auditor, with Authorised  
Public Accountant Timo Tuokko to be the primarily responsible auditor.          

In accordance with the Board's proposal, it was resolved that Articles of       
Association of the company will be changed as follows:                          

- Sections 3, 4 and 13 concerning share capital of the company, number of shares
and voting rights attached to the shares were wholly or partly removed as       
redundant.                                                                      
- Sections 8 and 9 concerning the right to sign for the company were amended to 
correspond to the wording of the Companies Act.                                 
- Section 11 concerning the notice of a General Meeting was amended to the      
effect that the notices can be delivered not earlier than three months prior to 
the General Meeting instead of the current two months.                          
- The list of matters to be considered at the Annual General Meeting of         
Shareholders was amended to correspond to the amended legislation.              
- The reference concerning the date of registration in section regarding the    
Book-entry System was removed as redundant.                                     
- Section concerning record date procedure was removed as redundant.            
- The numbering of the sections in the Articles of Association was amended      
correspondingly due to the above amendments.                                    

In accordance with the Board's proposal, it was resolved that the Board of      
Directors of the company is  authorized to resolve on the issuance of shares and
stock options and other special rights entitling to shares subject to chapter   
10, section 1 of the Companies Act as follows.                                  

The aggregate number of shares issued on the basis of the authorization may not 
exceed 10,000,000 shares. The Board of Directors is authorized to resolve on all
the terms and conditions concerning the issue of shares and stock options and   
other special rights entitling to shares. Issuance of shares and other special  
rights entitling to shares can be carried out as a directed issue. Authorization
is valid until further notice, however not more than five years from the        
decision by the Annual General Meeting of Shareholders.                         

Cencorp Corporation's interim financial statements based on companies act 20:23 

Cencorp Corporation published on June 29, 2007  interim financial statements    
January 1, 2007 - March 31, 2007 and report of the Board based on companies act 
20:23§. Documents are available at the Company's web site at www.cencorp.com    


CHANGES IN GROUP STRUCTURE                                                      

Kiinteistö Oy Salon Ratakatu 10, a real estate company owned by Cencorp         
Corporation, sold its factory hall and the related land lease agreement in      
December 2006. Since the real estate company's sole purpose was to administer   
the property traded, the company was decided to be dissolved through            
liquidation, which has been started by liquidator Attorney-at-Law Mr. Mikko     
Tuononen. Liquidation procedure will be finished before end of financial year   
2007.                                                                           


NOTIFICATIONS PURSUANT TO CHAPTER 2, SECTION 9, OF THE SECURITIES MARKET ACT    

No notifications pursuant to chapter 2, section 9, of the Securities Market Act 
were published during the review period.                                        


EVENTS AFTER THE REVIEW PERIOD                                                  

There were no published events after the review period                          



Business environment and customers                                              

Cencorp operates in the global market of production automation for the          
electronics and semiconductor industries. The company supplies production       
automation systems and testing equipment to the semiconductor,                  
telecommunications, consumer electronics, industrial electronics and automotive 
electronics industries as well as to the electronics contract manufacturers.    

The sales in the second quarter were emphasized quite evenly to all product     
groups. The prevailing boom in the metal industry in Finland caused challenges  
in purchasing components and machining parts. Thus, there were delays in        
deliveries of some customer projects and decrease in the margins.               

There was a major consolidation in the clientele as contract manufacturer       
Flextronics International announced to buy contract manufacturer Solectron      
Corporation.                                                                    
In order to respond better especially to the contract manufacturers' continuing 
improvement of  operations and cost-level cutting, Cencorp will launch a new    
product platform in Productronica Fair 2007 which is more economical but        
efficient.                                                                      
Special attention in the designing of the new product platform has been paid to 
the amount and price-level of the parts needed in the production. The purpose   
has been to half the amount of parts and components needed in the production.   

During the review period Cencorp delivered as planned the first Cencorp MTL-4   
testing equipments for software download application as well as the VIC 500 for 
vision testing equipment for quality control.                                   



Research and development                                                        

The R&D expenses for April-June totalled 6.5% of net sales, or EUR 0.3 (0.1)    
million of which no significant amounts were capitalised in the balance sheet.  



Board, management and personnel                                                 

At the end of the period, Cencorp Corporation's Board of Directors consisted of 
Mr. Jorma Kielenniva, Chairman, LL.M. with court training, Mr. Markku Jokela,   
Deputy Chairman, B.Sc. (Eng) and Mr. Sauli Kiuru, member, M.Sc. (Econ). The     
company's management team comprised of Mr. Jouni Suutarinen (CEO), Mr. Jarmo    
Kanervo (finance and administration), Mr. Ville Parpola (legal affairs and      
personnel), Mr. Kimmo Akiander (sales and marketing), Mr. Juha Kantola          
(production), Mr. Hannu Seppälä (testing business) and Mr. Pekka Kettunen       
(product development).                                                          

Cencorp employed an average of 129 (192) people from April to June. The payroll 
at the end of the period totalled 132 (187) employees: 113 (146), or 86% (78%), 
in Finland and 19 (41), or 14% (22%), abroad.                                   








Share performance and changes in ownership                                      

The price of the company's share ranged from EUR 0.27  (4-6/2006: EUR 0.68) to  
EUR 0.43 (4-6/2006: EUR 1.07) over the review period, the average share price   
being EUR 0.36 (4-6/2006: EUR 0.89). A total of   4,073,649 (4-6/2006:          
8,284,974) shares, or 11.9% (4-6/2006: 26.5%) of the company's entire share     
capital, were traded during the period.                                         

The company's market capitalisation at the end of the review period was EUR 14  
million (6/2006: EUR 22 million).                                               

At the end of the review period, the company had 5,870 registered shareholders  
(6/2006: 6,724). A total of  310,529  shares were nominee registered (6/2006:   
240,623), i.e., 0.91% (6/2006: 0.77 %). Cencorp had a total of   34,250,591     
shares outstanding at the end of the review period (6/2006: 31,250,591), and one
share series.                                                                   

Outlook for the future                                                          

More and more customers are looking for production solutions that are easily    
transferable according to demand between factories and continents. For this     
purpose standardized production equipment are most suitable. This change in its 
customer base has been noticed by Cencorp in its own strategy and because of    
this, the company moves to a fully standardized automation equipment            
manufacturer and supplier in the future.                                        

Cencorp focuses on four product categories in its operations: odd-form component
placement applications, PCB - sawing and routing products, test handlers of     
electronic products and laser applications.                                     

The first commercial solutions of the laser business are aimed to be brought on 
the market during the second half of the year 2007. The first commercial        
versions of the laser products are for PCB soldering and marking. Development   
version for PCB cutting will be launched simultaneously.                        

Technology partner of Cencorp, Corelase Oy, which was sold to Rofin-Sinar       
Technologies Inc. in April 2007 has informed that it will publish the commercial
version of the fibre laser (X-Lase) during the last quarter of year 2007.       

The Cencorp group's order backlog has developed positively. At the release      
moment the Cencorp group's order backlog was 6.4 million euros (2006: 2.2       
million euros). The sales for the whole year are expected to increase from year 
2006 and the operating profit (EBIT) for the second half of the year is         
estimated to be positive.                                                       

Because of the high economic cycle in the metal industry there was increase in  
the material costs in the second quarter and the margin level appeared below    
than anticipated. Thus, the company estimates the operating profit (EBIT) for   
the whole year will be negative.                                                



Future risks and uncertainty factors                                            

The most significant risks from Cencorp business perspective are related to the 
on-going tight financing situation as well as to the development of the sales.  
Cencorp's sales forecasts are based on the company's own views as well as the   
sales development estimates from customers and the distributor network.         


Interim Report Release                                                          

Cencorp Corporation will present its interim report 1-6/2007 to analysts,       
investors and the media on Tuesday, 21 August 2007, at 2:00 pm in Restaurant    
Savoy, Eteläesplanadi 14, 00130 Helsinki.                                       



Virkkala 21.8.2007                                                              

Cencorp Corporation                                                             

Board of Directors                                                              

Tables can be found on the following pages.                                     






--------------------------------------------------------------------------------
| CONSOLIDATED INCOME STATEMENT      |         |         |          |          |
--------------------------------------------------------------------------------
| (unaudited     |         |         |         |         |          |          |
| figures)       |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| EUR 1 000      | 4-6/200 | 4-6/200 | 1-6/200 | 1-6/200 | 1-12/200 |          |
|                | 7       | 6       | 7       | 6       | 6        |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Net sales      | 4 077   | 6 817   | 7 897   | 12 760  | 19 974   |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Other          | 103     | 49      | 140     | 127     | 446      |          |
| operating      |         |         |         |         |          |          |
| income         |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Expenses,      | -4 533  | -6 421  | -9 099  | -13 393 | -22 459  |          |
| total          |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Depreciations  | -283    | -304    | -592    | -595    | -1 309   |          |
| and            |         |         |         |         |          |          |
| write-downs    |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Operating      | -636    | 141     | -1 654  | -1 101  | -3 348   |          |
| result         |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Financial      | -334    | -332    | -651    | -529    | -1 526   |          |
| income and     |         |         |         |         |          |          |
| expenses       |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Result before  | -970    | -191    | -2 305  | -1 630  | -4 874   |          |
| taxes          |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Income taxes   | -13     | 14      | -12     | -13     | -25      |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Consolidated   | -983    | -177    | -2 317  | -1 643  | -4 899   |          |
| net result     |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| CONSOLIDATED BALANCE     |         |         |         |          |          |
| SHEET                    |         |         |         |          |          |
--------------------------------------------------------------------------------
| (unaudited     |         |         |         |         |          |          |
| figures)       |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| EUR 1 000      |         |         | 30.06.2 | 30.6.20 | 1-12/200 |          |
|                |         |         | 007     | 06      | 6        |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| ASSETS         |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Long-term      |         |         |         |         |          |          |
| assets         |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Tangible       |         |         | 1 672   | 2 124   | 1 778    |          |
| assets         |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Investment     |         |         | 337     | 977     | 343      |          |
| property       |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Goodwill       |         |         | 2 028   | 1 902   | 2 028    |          |
--------------------------------------------------------------------------------
| Other          |         |         | 587     | 1 404   | 1 016    |          |
| intangible     |         |         |         |         |          |          |
| assets         |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Incomplete product development     | 1 273   | 1 231   | 1 199    |          |
| projects                           |         |         |          |          |
--------------------------------------------------------------------------------
| Deferred tax   |         |         | 1 725   | 1 803   | 1 723    |          |
| asset          |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Available-fos-sale       |         | 17      | 20      | 17       |          |
| investments              |         |         |         |          |          |
--------------------------------------------------------------------------------
|                |         |         | 7 639   | 9 461   | 8 104    |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Short-term     |         |         |         |         |          |          |
| assets         |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Inventories    |         |         | 4 782   | 4 863   | 5 188    |          |
--------------------------------------------------------------------------------
| Accounts       |         |         | 3 837   | 8 250   | 5 589    |          |
| receivable     |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Other          |         |         | 1 075   | 690     | 1 323    |          |
| short-term     |         |         |         |         |          |          |
| assets         |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Cash and bank            |         | 923     | 292     | 937      |          |
| receivables              |         |         |         |          |          |
--------------------------------------------------------------------------------
|                |         |         | 10 617  | 14 095  | 13 037   |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Total assets   |         |         | 18 256  | 23 556  | 21 141   |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| LIABILITIES AND SHAREHOLDERS'      |         |         |          |          |
| EQUITY                             |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Shareholders'  |         |         |         |         |          |          |
| equity         |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Share capital  |         |         | 3 425   | 3 125   | 3 425    |          |
--------------------------------------------------------------------------------
| Other          |         |         | 4 432   | 4 158   | 4 432    |          |
| restricted     |         |         |         |         |          |          |
| equity         |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Fair value     |         |         |         | 441     |          |          |
| fund           |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Non-restricted |         |         | -7 533  | -2 886  | -5 224   |          |
| equity         |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Total          |         |         | 324     | 4 838   | 2 633    |          |
| shareholders'  |         |         |         |         |          |          |
| equity         |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Long-term      |         |         |         |         |          |          |
| liabilities    |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Long-term      |         |         | 10 426  | 5 484   | 10 356   |          |
| loans          |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Deferred tax   |         |         | 332     | 333     | 361      |          |
| liability      |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Long-term      |         |         |         | 129     |          |          |
| reserves       |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Total          |         |         | 10 758  | 5 946   | 10 717   |          |
| long-term      |         |         |         |         |          |          |
| liabilities    |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Short-term     |         |         |         |         |          |          |
| liabilities    |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Accounts payable and     |         | 4 599   | 6 282   | 4 450    |          |
| other liabilities        |         |         |         |          |          |
--------------------------------------------------------------------------------
| Short-term     |         |         | 1 298   | 5 190   | 1 394    |          |
| loans          |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Long-term loans          |         | 1 240   | 1 150   | 1 824    |          |
| shortening               |         |         |         |          |          |
--------------------------------------------------------------------------------
| Tax            |         |         |         | 13      | 25       |          |
| liabilities    |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Short-term     |         |         | 37      | 137     | 98       |          |
| reserves       |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Total          |         |         | 7 174   | 12 772  | 7 791    |          |
| short-term     |         |         |         |         |          |          |
| reserves       |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Total          |         |         |         |         |          |          |
| liabilities    |         |         |         |         |          |          |
--------------------------------------------------------------------------------
|                |         |         | 17 932  | 18 718  | 18 508   |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Total liabilities and    |         | 18 256  | 23 556  | 21 141   |          |
| shareholders' equity     |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY 1.1. -    |          |          |
| 30.6.2006                                              |          |          |
--------------------------------------------------------------------------------
| (unaudited figures)      |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|                | Share   | Other   | Transla | Retaine | Total    |          |
|                |         |         | tion    | d       |          |          |
--------------------------------------------------------------------------------
|                | capital | restric | differe | earning |          |          |
|                |         | ted     | nce     | s       |          |          |
--------------------------------------------------------------------------------
| EUR 1 000      |         | equity  |         |         |          |          |
--------------------------------------------------------------------------------
| Shareholders' equity     |         |         |         |          |          |
--------------------------------------------------------------------------------
| 31.12.2005     | 3 125   | 4 158   | -3 621  | 3 201   | 6 863    |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Translation    |         |         | -70     |         | -70      |          |
| difference     |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Net result     |         |         |         | -1 466  | -1 466   |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Shareholders'  |         |         |         |         |          |          |
| equity         |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| 30.06.2006     | 3 125   | 4 158   | -3 691  | 1 735   | 5 327    |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY 1.1. -    |          |          |
| 30.6.2007                                              |          |          |
--------------------------------------------------------------------------------
| (unaudited     |         |         |         |         |          |          |
| figures)       |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|                | Share   | Other   | Transla | Retaine | Total    |          |
|                |         |         | tion    | d       |          |          |
--------------------------------------------------------------------------------
|                | capital | restric | differe | earning |          |          |
|                |         | ted     | nce     | s       |          |          |
--------------------------------------------------------------------------------
| EUR 1 000      |         | equity  |         |         |          |          |
--------------------------------------------------------------------------------
| Shareholders'  |         |         |         |         |          |          |
| equity         |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| 31.12.2006     | 3 425   | 4 432   | -3 254  | -1 970  | 2 633    |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Translation    |         |         | -35     |         | -35      |          |
| difference     |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| IAS 12         |         |         |         | 43      | 43       |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Net result     |         |         |         | -2 317  | -2 317   |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Shareholders'  |         |         |         |         |          |          |
| equity         |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| 30.06.2007     | 3 425   | 4 432   | -3 289  | -4 244  | 324      |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Accounting Principles for the      |         |         |          |          |
| Interim Report:                    |         |         |          |          |
--------------------------------------------------------------------------------
| The same accounting policies and methods of            |          |          |
| computation are followed                               |          |          |
--------------------------------------------------------------------------------
| in the interim financial statements as compared with   |          |          |
| the most recent                                        |          |          |
--------------------------------------------------------------------------------
| interim financial        |         |         |         |          |          |
| statements.              |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Explanatory comments about the seasonality or          |          |          |
| cyclicality of interim                                 |          |          |
--------------------------------------------------------------------------------
| operations:    |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| The company operates in business areas which are       |          |          |
| subject to seasonal                                    |          |          |
--------------------------------------------------------------------------------
| fluctuations.  |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| CONSOLIDATED CASH FLOW STATEMENT   |         |         |          |          |
--------------------------------------------------------------------------------
| (unaudited     |         |         |         |         |          |          |
| figures)       |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| EUR 1 000      |         |         | 1-6/200 | 1-6/200 | 1-12/200 |          |
|                |         |         | 7       | 6       | 6        |          |
--------------------------------------------------------------------------------
| Cash flow from           |         | 714     | -339    | -2 908   |          |
| operations               |         |         |         |          |          |
--------------------------------------------------------------------------------
| Cash flow into and from  |         | -85     | -186    | 332      |          |
| investments              |         |         |         |          |          |
--------------------------------------------------------------------------------
| Financial cash |         |         | -643    | 439     | 3 187    |          |
| flow           |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Increase(+)/ decrease(-) in        | -14     | -86     | 611      |          |
| financial assets                   |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| GROUP KEY      |         |         |         |         |          |          |
| FIGURES        |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| (unaudited     |         |         |         |         |          |          |
| figures)       |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| EUR 1 000      |         | 4-6/200 | 4-6/200 | 1-6/200 | 1-6/2006 | 1-12/200 |
|                |         | 7       | 6       | 7       |          | 6        |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Net sales      |         | 4 077   | 6 817   | 7 897   | 12 760   | 19 974   |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Operating      |         | -636    | 141     | -1 654  | -1 101   | -3 348   |
| result         |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| % of net sales |         | -15.6 % | 2.1 %   | -20.9 % | -8.6 %   | -16.8 %  |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Result before  |         | -970    | -191    | -2 305  | -1 630   | -4 874   |
| taxes          |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| % of net sales |         | -23.8 % | -2.8 %  | -29.20  | -12.8 %  | -24.4 %  |
|                |         |         |         | %       |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Total assets   |         | 18 256  | 23 556  | 18 256  | 23 556   | 21 141   |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Equity ratio,  |         | 1.9 %   | 20.7 %  | 1.9 %   | 20.7 %   | 12.7 %   |
| %              |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Gearing ratio, |         | 4014.20 | 232.6 % | 4014.2  | 232.6 %  | 467.9 %  |
| %              |         | %       |         | %       |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Gross          |         | 40      | 69      | 85      | 186      | 436      |
| investments    |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| % of net sales |         | 1.0 %   | 1.0 %   | 1.1 %   | 1.5 %    | 2.2 %    |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| R&D            |         | 263     | 67      | 466     | 254      | 512      |
| expenditure    |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| % of net sales |         | 6.5 %   | 1.0 %   | 5.9 %   | 2.0 %    | 2.6 %    |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Personnel,     |         | 129     | 192     | 135     | 199      | 185      |
| average        |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Personnel, at end of     | 132     | 187     | 132     | 187      | 156      |
| period                   |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Non-interest bearing     | 4 371   | 6 790   | 4 371   | 6 790    | 4 835    |
| liabilities              |         |         |         |          |          |
--------------------------------------------------------------------------------
| Interest       |         | 14 157  | 11 530  | 14 157  | 11 530   | 14 610   |
| bearing        |         |         |         |         |          |          |
| liabilities    |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Per-share key  |         |         |         |         |          |          |
| figures        |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Equity per     |         | 0.01    | 0.15    | 0.01    | 0.15     | -0.14    |
| share*, EUR    |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Earnings per share,      | -0.04   | -0.01   | -0.09   | -0.05    | -0.15    |
| EUR/share (diluted)      |         |         |         |          |          |
|                          |         |         |         |          |          |
--------------------------------------------------------------------------------
| Earnings per share,      | -0.03   | -0.01   | -0.07   | -0.05    | 0.08     |
| EUR/share (undiluted)    |         |         |         |          |          |
|                          |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Share price    |         |         |         |         |          |          |
| trend          |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| High, euros    |         | 0.43    | 1.07    | 0.45    | 1.29     | 1.33     |
--------------------------------------------------------------------------------
| Low, euros     |         | 0.27    | 0.68    | 0.27    | 0.68     | 0.42     |
--------------------------------------------------------------------------------
| Average, euros |         | 0.36    | 0.89    | 0.37    | 0.99     | 0.81     |
--------------------------------------------------------------------------------
| Price at end of period,  | 0.40    | 0.71    | 0.40    | 0.71     | 0.44     |
| euros                    |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Market capitalization at | 14      | 22      | 14      | 22       | 15       |
| end of period, EUR       |         |         |         |          |          |
| millions                 |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| CALCULATION OF KEY       |         |         |         |          |          |
| FIGURES                  |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Equity ratio,  |         |         |         |         |          |          |
| %              |         |         |         |         |          |          |
--------------------------------------------------------------------------------
|                | Shareholders' equity + minority       |          |          |
|                | interest x 100                        |          |          |
--------------------------------------------------------------------------------
|                | Balance sheet total -       |         |          |          |
|                | advances received           |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Net gearing, % |         |         |         |         |          |          |
--------------------------------------------------------------------------------
|                | Interest-bearing liabilities - cash   |          |          |
|                | and cash                              |          |          |
--------------------------------------------------------------------------------
|                | equivalents and marketable securities |          |          |
|                | x 100                                 |          |          |
--------------------------------------------------------------------------------
|                | Shareholders' equity +      |         |          |          |
|                | minority interest           |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Earings per    |         |         |         |         |          |          |
| share (EPS)    |         |         |         |         |          |          |
--------------------------------------------------------------------------------
|                | Profit before extraordinary items +/- |          |          |
|                | minority                              |          |          |
--------------------------------------------------------------------------------
|                | interest of profit/loss for the       |          |          |
|                | period - taxes                        |          |          |
--------------------------------------------------------------------------------
|                | Number of shares adjusted for share   |          |          |
|                | issue (average)                       |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Equity per     |         |         |         |         |          |          |
| share          |         |         |         |         |          |          |
--------------------------------------------------------------------------------
|                | Shareholders'     |         |         |          |          |
|                | equity            |         |         |          |          |
--------------------------------------------------------------------------------
|                | Number of shares adjusted for share   |          |          |
|                | issue                                 |          |          |
--------------------------------------------------------------------------------
|                | at the end of the financial |         |          |          |
|                | year                        |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| CONTINGENT LIABILITIES   |         |         |         |          |          |
--------------------------------------------------------------------------------
| (unaudited     |         |         |         |         |          |          |
| figures)       |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| EUR 1 000      |         |         | 30.06.2 | 30.06.2 | 31.12.20 |          |
|                |         |         | 007     | 006     | 06       |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Loans from financial     |         | 12 712  | 7 439   | 13 069   |          |
| institutions             |         |         |         |          |          |
--------------------------------------------------------------------------------
| Corporate mortgages      |         | 12 452  | 12 452  | 12 687   |          |
| granted                  |         |         |         |          |          |
--------------------------------------------------------------------------------
| Real-estate mortgages    |         | 12 687  | 168     | 0        |          |
| granted                  |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Other loans    |         |         | 1 445   | 1 758   | 1 541    |          |
--------------------------------------------------------------------------------
| Real-estate mortgages    |         | 0       | 0       | 0        |          |
| granted                  |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Used bank guarantee      |         | 0       | 0       | 151      |          |
| facility                 |         |         |         |          |          |
--------------------------------------------------------------------------------
| Real-estate mortgages    |         | 0       | 0       | 0        |          |
| granted                  |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Given as       |         |         |         |         |          |          |
| collateral     |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| Corporate mortgages      |         | 12 687  | 12 687  | 12 687   |          |
| granted, total           |         |         |         |          |          |
--------------------------------------------------------------------------------
| Real-estate mortgages    |         | 0       | 168     | 0        |          |
| granted, total           |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Leasing        |         |         |         |         |          |          |
| commitments    |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| falling due during the   |         | 89      | 118     | 112      |          |
| next 12 months           |         |         |         |          |          |
--------------------------------------------------------------------------------
| falling due    |         |         | 64      | 110     | 103      |          |
| later          |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Rental         |         |         |         |         |          |          |
| liabilities    |         |         |         |         |          |          |
--------------------------------------------------------------------------------
| falling due during the   |         | 66      | 140     | 59       |          |
| next 12 months           |         |         |         |          |          |
--------------------------------------------------------------------------------
| falling due    |         |         | 70      | 156     | 59       |          |
| later          |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Liabilities due to       |         |         |         |          |          |
| derivative contracts     |         |         |         |          |          |
--------------------------------------------------------------------------------
| Forward exchange         |         | 0       | 0       | 0        |          |
| contracts                |         |         |         |          |          |
--------------------------------------------------------------------------------
| of which taken out to hedge the    | 0       | 0       | 0        |          |
| parent company's accounts          |         |         |          |          |
| receivable                         |         |         |          |          |
--------------------------------------------------------------------------------
| of which taken out to hedge the    | 0       | 0       | 0        |          |
| parent company's other receivables |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| TRANSACTIONS WITH RELATED PARTIES  |         |         |          |          |
--------------------------------------------------------------------------------
| (unaudited     |         |         |         |         |          |          |
| figures)       |         |         |         |         |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| EUR 1 000      |         |         | 1-6/200 | 1-12/20 |          |          |
|                |         |         | 7       | 06      |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Sales of goods and       |         |         |         |          |          |
| services                 |         |         |         |          |          |
--------------------------------------------------------------------------------
|  Related party companies |         |         |         |          |          |
--------------------------------------------------------------------------------
|   Photonium Oy |         |         | 282     | 357     |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Purchases of goods and   |         |         |         |          |          |
| services                 |         |         |         |          |          |
--------------------------------------------------------------------------------
|  Related party companies |         |         |         |          |          |
--------------------------------------------------------------------------------
|   Photonium Oy |         |         | 369     | 1006    |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Fees paid on the basis of          |         |         |          |          |
| consultation agreements            |         |         |          |          |
--------------------------------------------------------------------------------
|  Related party companies |         |         |         |          |          |
--------------------------------------------------------------------------------
|  FT-Capital Oy |         |         | 13      | 25      |          |          |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Convertible subordinated loans     | 650     | 650     |          |          |
| from related parties               |         |         |          |          |
--------------------------------------------------------------------------------
| Accounts payable to      |         | 44      | 512     |          |          |
| related parties          |         |         |         |          |          |
--------------------------------------------------------------------------------
| Other receivables from   |         | 622     | 447     |          |          |
| related parties          |         |         |         |          |          |
--------------------------------------------------------------------------------
| Accounts receivables from related  | 356     | 337     |          |          |
| parties                            |         |         |          |          |
--------------------------------------------------------------------------------




For more information, please contact:                                           

Jouni Suutarinen                                                                
President and CEO	 		                                                           
Tel. +358 (0)19  6610 100                                                       

Cencorp supplies the electronics and semiconductor industries with automation   
solutions that enhance productivity.                                            


DISTRIBUTION: Helsinki Stock Exchange and the media                             

Neither this press release nor any copy of it may be taken, transmitted into or 
distributed in the United States of America or its territories or possessions.